-
1.发明授权公开(公告)号：US09302981B2
公开(公告)日：2016-04-05
申请号：US14203364
申请日：2014-03-10
发明人： Laxminarayan Bhat , Seema Rani Bhat
IPC分类号： C07C229/34 , C07C229/14 , C07C271/16
CPC分类号： C07C229/34 , C07C229/14 , C07C271/16 , C07C2601/04
摘要： The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications.
摘要翻译： 本发明提供新的环烷基甲胺类似物，以及制备环烷基甲胺类似物的方法。 本发明还提供了使用环烷基甲胺类似物和环烷基甲胺类似物的组合物的方法。 本发明化合物的药物组合物可有利地用于治疗和/或预防肥胖和肥胖相关并发症的适应症。
-
2.发明申请公开(公告)号：US20140194508A1
公开(公告)日：2014-07-10
申请号：US14203364
申请日：2014-03-10
发明人： Laxminarayan BHAT , Seema Rani Bhat
IPC分类号： C07C229/14
CPC分类号： C07C229/34 , C07C229/14 , C07C271/16 , C07C2601/04
摘要： The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications.
摘要翻译： 本发明提供新的环烷基甲胺类似物，以及制备环烷基甲胺类似物的方法。 本发明还提供了使用环烷基甲胺类似物和环烷基甲胺类似物的组合物的方法。 本发明化合物的药物组合物可有利地用于治疗和/或预防肥胖和肥胖相关并发症的适应症。
-
公开(公告)号：US08461154B2
公开(公告)日：2013-06-11
申请号：US13465549
申请日：2012-05-07
IPC分类号： C07D417/10 , A61K31/5415
CPC分类号： C07D265/36 , A61K31/538 , C07D413/12
摘要： The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.
摘要翻译： 本发明提供了具有式I的芳基哌嗪衍生物，其可有利地用于治疗精神分裂症和相关精神病如急性躁狂症，双相情感障碍，自闭症和抑郁症。
-
4.发明授权Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors 失效使用茚酮基胆碱酯酶抑制剂的组合物，合成方法和方法公开(公告)号：US08247563B2
公开(公告)日：2012-08-21
申请号：US12001582
申请日：2007-12-11
IPC分类号： C07D401/00 , A61K31/445
CPC分类号： C07D211/22 , C07D401/06 , C07D401/12
摘要： The present invention provides novel indanone derivatives which can be advantageously used for treating and/or preventing of a medical condition for which inhibition of a cholinesterase is desired.
摘要翻译： 本发明提供了可有利地用于治疗和/或预防需要抑制胆碱酯酶的医学病症的新型茚酮衍生物。
-
5.发明授权Compositions, synthesis, and methods of utilizing arylpiperazine derivatives 有权利用芳基哌嗪衍生物的组合物，合成方法和方法公开(公告)号：US08188076B2
公开(公告)日：2012-05-29
申请号：US12714406
申请日：2010-02-26
IPC分类号： C07D413/12 , A61K31/538
CPC分类号： C07D265/36 , A61K31/538 , C07D413/12
摘要： The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.
摘要翻译： 本发明提供了具有式I的芳基哌嗪衍生物，其可有利地用于治疗精神分裂症和相关精神病如急性躁狂症，双相情感障碍，自闭症和抑郁症。
-
公开(公告)号：US20110263704A1
公开(公告)日：2011-10-27
申请号：US13176512
申请日：2011-07-05
申请人： Laxminarayan Bhat , Seema Rani Bhat
发明人： Laxminarayan Bhat , Seema Rani Bhat
IPC分类号： A61K31/24 , A61P1/08 , A61P25/00 , A61P25/28 , A61P1/00 , A61P7/00 , A61P25/24 , A61P25/18 , A61P25/22 , A61P25/20 , A61P15/00 , A61P25/14 , A61P19/02 , A61P25/30 , A61P25/04 , A61P25/06 , A61P13/00 , A61P3/04
CPC分类号： C07C229/34 , C07C229/14 , C07C271/16 , C07C2601/04
摘要： The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications.
摘要翻译： 本发明提供新的环烷基甲胺类似物，以及制备环烷基甲胺类似物的方法。 本发明还提供了使用环烷基甲胺类似物和环烷基甲胺类似物的组合物的方法。 本发明化合物的药物组合物可有利地用于治疗和/或预防肥胖和肥胖相关并发症的适应症。
-
公开(公告)号：US12053477B2
公开(公告)日：2024-08-06
申请号：US17656743
申请日：2022-03-28
发明人： Laxminarayan Bhat
IPC分类号： A61K31/538 , A61K9/00 , A61P11/00
CPC分类号： A61K31/538 , A61K9/0053 , A61P11/00
摘要： The present invention provides a method of using arylpiperazine derivatives for treating pulmonary fibrosis. The method comprises a step of administering to a pulmonary fibrosis patient in need thereof an effective amount of a compound of Formula 1, which is an arylpiperazine derivative.
-
公开(公告)号：US20140024709A1
公开(公告)日：2014-01-23
申请号：US14038543
申请日：2013-09-26
发明人： Laxminarayan BHAT , Kouacou ADIEY
IPC分类号： C07C271/20 , C07C229/34
CPC分类号： C07C69/34 , C07C69/96 , C07C209/48 , C07C209/88 , C07C211/26 , C07C213/06 , C07C213/10 , C07C217/74 , C07C219/06 , C07C229/34 , C07C231/02 , C07C237/06 , C07C237/22 , C07C271/20 , C07C2601/04
摘要： The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
摘要翻译： 本发明提供新的环烷基甲基胺衍生物，以及制备环烷基甲基胺衍生物的方法。 本发明还提供了使用环烷基甲基胺衍生物和环烷基甲基胺衍生物的组合物的方法。 本发明化合物的药物组合物可以有利地用于治疗和/或预防肥胖和肥胖相关并发症适应症和抑郁症和抑郁症相关并发症的适应症。
-
9.发明申请COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES 有权组合物，合成方法和使用苯基甲基吗啉衍生物的方法公开(公告)号：US20140024679A1
公开(公告)日：2014-01-23
申请号：US13731670
申请日：2012-12-31
IPC分类号： C07D211/34 , C07C317/50 , C07D207/09 , C07C211/27
CPC分类号： C07C317/28 , C07C211/27 , C07C211/29 , C07C217/08 , C07C217/74 , C07C317/18 , C07C317/50 , C07C323/25 , C07C323/32 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D207/09 , C07D211/34
摘要： The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
摘要翻译： 本发明提供新的苯基环烷基甲基胺衍生物，以及制备苯基环烷基甲基胺衍生物的方法。 本发明还提供使用苯基环烷基甲基胺衍生物和苯基环烷基甲胺衍生物的组合物的方法。 本发明化合物的药物组合物可用于治疗和/或预防肥胖和肥胖相关并发症适应症和抑郁症和抑郁症相关并发症的适应症。
-
10.发明授权Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives 有权使用环烷基甲胺衍生物的组合物，合成方法和方法公开(公告)号：US08604244B2
公开(公告)日：2013-12-10
申请号：US13175824
申请日：2011-07-01
申请人： Laxminarayan Bhat , Kouacou Adiey
发明人： Laxminarayan Bhat , Kouacou Adiey
IPC分类号： C07C211/00 , A01N33/02 , A61K31/135
CPC分类号： C07C69/34 , C07C69/96 , C07C209/48 , C07C209/88 , C07C211/26 , C07C213/06 , C07C213/10 , C07C217/74 , C07C219/06 , C07C229/34 , C07C231/02 , C07C237/06 , C07C237/22 , C07C271/20 , C07C2601/04
摘要： The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
摘要翻译： 本发明提供新的环烷基甲基胺衍生物，以及制备环烷基甲基胺衍生物的方法。 本发明还提供了使用环烷基甲基胺衍生物和环烷基甲基胺衍生物的组合物的方法。 本发明化合物的药物组合物可以有利地用于治疗和/或预防肥胖和肥胖相关并发症适应症和抑郁症和抑郁症相关并发症的适应症。
-
-
-
-
-
-
-
-
-
搜索结果
43 条记录 (耗时 0.027 秒)
